Substipharm is a privately held French pharmaceutical group, headquartered in Paris, that develops, supplies, and commercialises pharmaceutical products in over 80 countries worldwide. With a robust product pipeline comprising more than 50 ongoing projects, Substipharm concentrates on niche and differentiating products based on technology and market size. The company either markets these products directly or licenses them to other pharmaceutical companies, depending on the region of operation.

Services include:
• Finished Dosage Forms
• Pharmaceutical Generics
• Active Pharmaceutical Ingredients
• Contract Manufacturing (CMO/CDMO)

Substipharm takes pride in its successful portfolio of pharmaceutical products and dossiers, reflecting its commitment to innovation and quality in the pharmaceutical industry. For more information, please visit substipharm.com.